A guidance on the changes appropriate for remote patient monitoring devices being used in homes was revised to reflect the end of the COVID-19 public health emergency, but not much has changed.
The Food and Drug Administration’s enforcement policy for non-invasive remote monitoring devices used to support patient monitoring guidance document sets out policies for the transition of non-invasive devices from...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?